Study of HBV-001 D1 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

January 31, 2011

Conditions
Dengue Fever
Interventions
BIOLOGICAL

DEN1-80E (HBV-001 D1 + 3.5 mg Alhydrogel)

3 doses of DEN1-80E vaccine administered as 0.5 ml intramuscularly in deltoid.

BIOLOGICAL

Placebo for DEN1-80E

3 doses of placebo vaccine administered as 0.5 ml intramuscularly in deltoid.

Trial Locations (1)

63104

Saint Louis University, St Louis

Sponsors
All Listed Sponsors
lead

Hawaii Biotech, Inc.

INDUSTRY